Biocardia Correlations
| BCDA Stock | USD 1.27 0.02 1.60% |
The current 90-days correlation between Biocardia and Creative Medical Technology is -0.09 (i.e., Good diversification). The correlation of Biocardia is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Biocardia Correlation With Market
Significant diversification
The correlation between Biocardia and DJI is 0.07 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Biocardia and DJI in the same portfolio, assuming nothing else is changed.
Biocardia | Build AI portfolio with Biocardia Stock |
Moving against Biocardia Stock
| 0.52 | XOM | Exxon Mobil Corp | PairCorr |
| 0.5 | TRV | The Travelers Companies | PairCorr |
| 0.46 | GE | GE Aerospace | PairCorr |
| 0.44 | JPM | JPMorgan Chase Earnings Call This Week | PairCorr |
| 0.4 | AMGN | Amgen Inc | PairCorr |
| 0.37 | FTV | Fortive Corp | PairCorr |
| 0.36 | MRK | Merck Company | PairCorr |
| 0.35 | BAC | Bank of America Earnings Call This Week | PairCorr |
| 0.31 | CSCO | Cisco Systems | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Biocardia Stock performing well and Biocardia Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Biocardia's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CELZ | 4.71 | (0.47) | 0.00 | (0.14) | 0.00 | 8.61 | 50.90 | |||
| APRE | 3.16 | (0.86) | 0.00 | (0.28) | 0.00 | 4.40 | 17.87 | |||
| ACXP | 6.38 | (0.19) | 0.00 | (0.04) | 0.00 | 10.99 | 100.00 | |||
| KPRX | 2.74 | (0.50) | 0.00 | (0.23) | 0.00 | 5.32 | 21.80 | |||
| HCWB | 5.01 | (1.59) | 0.00 | 11.30 | 0.00 | 13.02 | 42.33 | |||
| ALZN | 2.96 | (0.32) | 0.00 | (0.08) | 0.00 | 6.10 | 21.59 | |||
| ADIL | 2.93 | (0.49) | 0.00 | (1.64) | 0.00 | 6.67 | 18.11 | |||
| INAB | 4.64 | 0.11 | 0.05 | 0.13 | 4.60 | 14.29 | 37.96 | |||
| PHIO | 3.04 | (1.14) | 0.00 | (0.70) | 0.00 | 4.65 | 19.15 | |||
| APVO | 4.56 | (1.69) | 0.00 | (0.78) | 0.00 | 7.81 | 59.53 |
Biocardia Corporate Management
| Edward Gillis | Senior Devices | Profile | |
| Ian McNiece | Chief Officer | Profile | |
| Sujith Shetty | Chief Regulatory | Profile | |
| Sujith MBBS | Chief Regulatory | Profile | |
| Miranda Benvenuti | Investor Executive | Profile |